Midi Health vs Foundayo

Compare pricing, features, and medications to find the best GLP-1 provider for your weight loss journey

Midi Health vs Foundayo: Overview

Choosing between Midi Health and Foundayo for GLP-1 weight loss medication? Both are highly-rated providers, but they differ in pricing, medication options, and service features.

Midi Health offers both semaglutide and tirzepatide at $164/month with a rating of 8.6/10. Foundayo offers orforglipron at $149/month with a 9.2/10 rating.

With only a $15/month price difference, your choice will likely come down to features, support quality, and medication options.

VERIFIED

Our recommended brand

After reviewing all 148 providers on this platform, we've identified CoreAge Rx as offering the most transparent pricing model. At just $99/month — the same price every month, every dose — there are no surprise charges or hidden fees. Combined with exceptional service quality, personalized support, and access to both semaglutide and tirzepatide, it represents the best value without compromising on care.

At a glance

Price Difference
$15/mo
Rating Difference
0.6
Winner
Foundayo
Best For
Budget

Midi Health

View full Midi Health review →
Rating
8.6/10
Monthly Price
$164
Medications
compounded GLP-1compounded GLP-1/GIPbrand-name GLP-1s

Pros

  • The GLP-1 pricing page is the most transparent we have seen anywhere in this category: a dose-by-dose table for four different products, with shipping and supplies included in every figure (checked July 28, 2026)
  • Compounded GLP-1 injectable runs $165.90 for the lowest doses, $270.90 in the mid range and $355.00 at the top; the dual-action GLP-1/GIP injectable runs $210.00 to $434.00, all for a 4-week supply
  • Sublingual options are offered as well, from $164.00 for GLP-1 and $209.00 for dual-action GLP-1/GIP, for people who will not inject
  • Its partner compounding pharmacies are 503B-accredited. 503B outsourcing facilities register with the FDA, are subject to current good manufacturing practice requirements and are FDA-inspected - a materially higher standard than the 503A pharmacies most competitors use
  • There is no membership fee. You pay for care and medication only
  • Visits are insurance-covered for qualifying patients, and HSA/FSA funds can be used for copays and services
  • Midi will also prescribe brand-name GLP-1s sent to a pharmacy of your choice, so you are not locked into compounded product if you would rather have the approved drug
  • The efficacy claim is the best-sourced in this category. Midi reports patients lost an average of 16 lbs after six or more months, and footnotes it to a retrospective analysis of 6,958 patients who completed two or more weight management visits between 1 May 2025 and 30 April 2026, while stating plainly that weight data were self-reported and results are not guaranteed
  • Care is genuinely whole-person for midlife women - perimenopause, menopause, weight, mood and memory, sexual wellness, hair and skin, sleep, and cancer survivorship - with lab orders and lifestyle support included where appropriate
  • Available in all 50 states

Cons

  • The compounded products are still not FDA-approved. 503B accreditation raises the manufacturing standard considerably but does not mean the FDA has reviewed these preparations for safety or efficacy
  • Midi never names the active drug anywhere in its pricing. Everything is labelled 'GLP-1' or 'GLP-1/GIP'. The dose ladders shown - 0.25 through 2.5 mg, and 2.5 through 15 mg - match the standard semaglutide and tirzepatide titrations exactly, but you should confirm with the clinician what you are actually being prescribed
  • Microdosing is offered from $34 a week for eligible patients. Microdosing is not an evidence-based protocol - the trials behind these drugs used full therapeutic doses, and the 16 lb outcome figure covers patients on 'a range of treatments', not microdosing specifically
  • Medicaid and Medi-Cal patients cannot be treated at all, even if they offer to pay cash
  • Medicare does not cover Midi, and beneficiaries cannot submit claims for visits, medications or associated services
  • Prices rise steeply as you titrate up. Injectable GLP-1 more than doubles from $165.90 to $355.00, and the dual-action sublingual runs from $209.00 to $460.00, so the entry price is not what you will pay long term
  • The 16 lb average comes from self-reported weights in a retrospective chart review with no control group - well documented, but not a controlled trial
  • GLP-1 medications are not suitable for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, or during pregnancy. Pancreatitis and gallbladder disease are recognised risks
Choose Midi Health

Foundayo

View full Foundayo review →
Rating
9.2/10Better
Monthly Price
$149Cheaper
Medications
orforglipron

Pros

  • The first and only FDA-approved GLP-1 pill for weight loss that can be taken at any time of day with no food or water restrictions, approved 1 April 2026
  • In the ATTAIN-1 trial, participants on the highest dose who stayed on treatment lost an average of 27.3 pounds (12.4% of body weight) against 2.2 pounds (0.9%) on placebo
  • Counting everyone randomised regardless of whether they finished, the average was still 25 pounds (11.1%) versus 5.3 pounds (2.1%) on placebo - Lilly published both numbers rather than only the flattering one
  • A once-daily tablet, so there is no injection, no needle disposal and no refrigeration to organise
  • Self-pay pricing is published up front at $149 per month for the lowest dose through LillyDirect, with free home delivery
  • Eligible people with commercial insurance may pay as little as $25 per month with the Foundayo savings card
  • Eligible Medicare Part D patients may be able to get it for $50 per month from as early as 1 July 2026 - a rarity in this category
  • Lilly reported reductions in waist circumference, non-HDL cholesterol, triglycerides and systolic blood pressure across all doses
  • It is a small-molecule (non-peptide) GLP-1, which is why it can be manufactured as a pill rather than an injection

Cons

  • Weight loss is meaningfully lower than the best injectables. 12.4% at the top dose sits below tirzepatide territory, so if maximum weight loss is the goal an injection still wins
  • It carries the class boxed warning: it may cause thyroid tumours including thyroid cancer, and must not be used by anyone with a personal or family history of medullary thyroid carcinoma or MEN 2
  • Should not be used alongside another GLP-1 receptor agonist
  • Common side effects include nausea, constipation, diarrhoea, vomiting, indigestion, abdominal pain, headache, fatigue, heartburn, gas and hair loss
  • Serious risks in the label include pancreatitis, dehydration leading to kidney problems, gallbladder problems, severe allergic reactions and aspiration risk under anaesthesia
  • Safety and effectiveness in children have not been established
  • $149 is the price of the lowest dose only - higher doses cost more, and the $25 and $50 figures depend on insurance eligibility rather than being available to everyone
  • Very new to market, so there is no long-term real-world safety and adherence record yet
Choose Foundayo

Feature-by-feature comparison

FeatureMidi HealthFoundayo
Monthly Price$164$149
Rating8.6/109.2/10
Medicationscompounded GLP-1, compounded GLP-1/GIP, brand-name GLP-1sorforglipron
Insurance AcceptedYesYes
Support HoursNot publishedNot published
Live ChatNoNo
Free ShippingYesYes
Shipping SpeedDiscreet shipping included in every quoted medication priceFree home delivery via LillyDirect; shipping began 6 April 2026
Mobile AppNoNo
Dedicated CoachNot includedNot included
Follow-up FrequencyContinued care visits with the same clinician, covered by insurance for qualifying patientsAs directed by your prescriber
Money-back GuaranteeNone publishedNone published; this is a prescription medicine, not a subscription service
Cancellation PolicyNo membership fee and no subscription lock-in; you pay for care and medication onlyPrescription-based - stopping treatment is a decision for you and your prescriber

Which should you choose?

Choose Midi Health if you:

  • Want more medication options to choose from
  • Value: the glp-1 pricing page is the most transparent we have seen anywhere in this category: a dose-by-dose table for four different products, with shipping and supplies included in every figure (checked july 28, 2026)

Choose Foundayo if you:

  • Want to save $15/month with a more affordable option
  • Prefer a higher-rated service (9.2/10 vs 8.6/10)
  • Value: the first and only fda-approved glp-1 pill for weight loss that can be taken at any time of day with no food or water restrictions, approved 1 april 2026

Website previews

Midi Health

Midi Health website

Foundayo

Foundayo website

Our recommendation

Foundayo comes out ahead with a higher rating of 9.2/10.
Get started with Foundayo

Compare other providers

Compare GLP-1 Brands